EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

4D-DIA proteomic analysis of human placenta in fetal intrauterine growth restriction

Yuanyuan Dang, Xiaoxiao Kong, Tian Yang, Qiuhong Yu, Ping Chen, Mingli Lyu

Frontiers in Medicine · 29.07.2026 · 13

DOI: 10.3389/fmed.2026.1842267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 29.07.2026. Verfasst von Yuanyuan Dang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Diagnosis, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiaotong University, Sh…. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introdution Approximately 60% of fetal intrauterine growth restriction (FGR) cases result from placental dysfunction. 4D-DIA proteomic chips can efficiently identify differentially expressed proteins (DEPs), to explore FGR pathophysiology mechanism caused by placenta dysfuntion.

Methods

This study aimed to identify differentially expressed proteins (DEPs) in placentas from 10 FGR and 10 normal participants using 4D-DIA proteomic chips, by comparing fetal- and maternal-side placental tissues in both groups. GO enrichment and KEGG pathway analyses were applied to interpret the biological functions of DEPs, and ELISA was used to validate candidate proteins in an additional 8 FGR and 10 normal placentas.

Results

In total, 249 DEPs were identified between maternal and fetal sides in the control group (CON-M vs CON-F), whereas only 158 DEPs were found in the FGR group (FGR-M vs FGR-F). Between-group comparisons of the same placental side showed 278 DEPs in FGR-F vs CON-F and 157 DEPs in FGR-M vs CON-M. Candidate proteins included PRPF38A(down-regulated), PRPF38B(up-regulated), THOC2(down-regulated) which associate with mRNA splicing via spliceosome and COX6C(down-regulated), COX7B(up-regulated) which participanting in oxidative phosphorylation).

Discussion

The fetal placental compartment may be the primary contributor to placental dysfunction, and these proteins may be crucial in FGR pathophysiology, requiring further research.

Schlagwörter

Stichwörter der Autor:innen

ELISAFGRhumanplacentaproteomic analysis

Autor:innen und Institutionen

  • Department of Ultrasound Diagnosis, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, China.
  • Institute of Birth Defects and Rare Diseases, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

Zitieren

APA

Dang, Y., Kong, X., Yang, T., Yu, Q., Chen, P., & Lyu, M. (2026). 4D-DIA proteomic analysis of human placenta in fetal intrauterine growth restriction. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1842267

Vancouver

Dang Y, Kong X, Yang T, Yu Q, Chen P, Lyu M. 4D-DIA proteomic analysis of human placenta in fetal intrauterine growth restriction. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1842267

BibTeX
@article{Dang2026,
  author = {Dang, Yuanyuan and Kong, Xiaoxiao and Yang, Tian and Yu, Qiuhong and Chen, Ping and Lyu, Mingli},
  title = {4D-DIA proteomic analysis of human placenta in fetal intrauterine growth restriction},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1842267}
}
Kostenlos starten →